Pharmagest Interactive SA
LSE:0R9T
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharmagest Interactive SA
LSE:0R9T
|
FR |
|
Alligator Bioscience AB
F:7AL0
|
SE |
Wall St Price Targets
0R9T Price Targets Summary
Pharmagest Interactive SA
According to Wall Street analysts, the average 1-year price target for 0R9T is 51.94 EUR with a low forecast of 51.43 EUR and a high forecast of 53.47 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0R9T's stock price target?
Price Target
51.94
EUR
According to Wall Street analysts, the average 1-year price target for 0R9T is 51.94 EUR with a low forecast of 51.43 EUR and a high forecast of 53.47 EUR.
What is the Revenue forecast for Pharmagest Interactive SA?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 8%.
What is the Gross Profit forecast for Pharmagest Interactive SA?
Projected CAGR
-4%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 6 years is -4%.
What is the Operating Income forecast for Pharmagest Interactive SA?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 3 years is 12%.
What is the Pre-Tax Income forecast for Pharmagest Interactive SA?
Projected CAGR
15%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 15%.
What is the Net Income forecast for Pharmagest Interactive SA?
Projected CAGR
14%
Over the last 14 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 3 years is 14%.
